Tumour-informed liquid biopsies can be used for treatment monitoring and detection of relapse in melanoma patients during or after immunotherapy. Here, the authors utilise targeted sequencing to monitor variants in advanced melanoma patients in ctDNA and show ctDNA could be detected in adjuvant patients.
- Christopher Schroeder
- Sergios Gatidis
- Andrea Forschner
